Open AccessErratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)
Author(s) -
Andrew D. Santeusanio,
Monica M. Bowen
Publication year - 2018
Publication title -
diabetes spectrum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.716
H-Index - 31
eISSN - 1944-7353
pISSN - 1040-9165
DOI - 10.2337/ds18-er04
Subject(s) - medicine , metformin , sulfonylurea , basal insulin , insulin , diabetes mellitus , basal (medicine) , term (time) , endocrinology , type 2 diabetes , physics , quantum mechanics
[This corrects the article on p. 261 in vol. 31, PMID: 30140142.].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom